Contract Research Organization (CRO) Services Market by Service Type [Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post Approval Services], Therapeutic Area [Oncology, Endocrinology, Immunological Disorders, Respiratory Disorders, Neurology, Hematology, Infectious Diseases, and CVS], End User [Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Academic Institutes] – Global Analysis & Forecast 2021-2031
Clairvoyance Research conducted an in-depth market analysis study of the global contract research organization (CRO) services market. According to the study, the market was valued at ~US$ 48.6 billion in 2020. The market is expected to witness a healthy CAGR of ~10.5% from 2021 to 2031.
Growing adoption of decentralized/virtual clinical trial models, rising demand for effective therapies owing to the growing prevalence of various chronic diseases, increasing outsourcing of R&D activities, globalization of clinical trials, and growing strategic collaborations of pharmaceutical and biotechnology companies with CROs are some of the pivotal factors propelling the growth of the contract research organization (CRO) services market. However, the dearth of skilled professionals is likely to hinder the growth of the market to a certain extent.
Shift from In-House R&D to Outsourcing to CROs Set to Bolster the Contract Research Organization (CRO) Services Market
Constantly evolving industry regulations, increasing competition, and rising demand for new & effective treatment options have urged the biotech & pharma companies to continuously explore innovative technologies and evaluate R&D outsourcing options. Outsourcing research activities to CROs allows healthcare companies to stay competitive, flexible, and profitable against all odds. As CROs often have deeper knowledge & experience in the fields of research, outsourcing of R&D activities allows healthcare companies to leverage therapeutic areas & operational expertise, geographic reach, and well-established tools of CROs. CROs are capable to undertake functions of all stages of the drug development process (i.e., discovery & development, preclinical research, clinical research, and post-approval monitoring) more effectively and faster as compared to in-house research & development teams of healthcare companies. Outsourcing of R&D activities also allows healthcare companies to conserve their limited resources for the most value-adding activities.
Decentralized Clinical Trials/Virtual Clinical Trials - Digital Revolution in Clinical Trials
The sudden outbreak of the COVID-19 pandemic has disrupted the traditional drug-testing paradigm by interrupting drug trials & site visits. The clinical supply chain was disrupted, the participant enrollment was put off and the development of many treatments was delayed. The unprecedented scenario adversely impacted pharmaceutical & biotechnology company's capability to maintain continuity in studies and reach patients. The patient's access to the trial site was reduced by around 75-80% due to physical distancing and lockdown restrictions. Whereas, in May 2020, investigators reported around 60% reduction in trial activities.
To alleviate the adverse effect of COVID-19, companies started adopting decentralized/hybrid/virtual clinical trial models and collaborated with virtual trial platform vendors and remote monitoring solutions providers to support decentralized trial models. The pandemic has significantly boosted the adoption of decentralized clinical trials owing to its benefits and its ability to improve patient & physician experience. It allows maintaining the links to trial participants without the need for in-person visits, with the help of tools like electronic consent, telehealthcare, remote patient monitoring, and electronic clinical outcome assessments (eCOAs). The shift in drug trials from a physical site-centric approach to a hybrid or decentralized model has allowed to access a large & diverse pool of patients. It has also improved the reliability and accuracy of data obtained.
Dearth of Skilled & Experienced Professionals – A Key Challenge
There has been a growing challenge of lack of experienced clinical staff in the CRO industry, as the demand for CRO services increases. The lack of qualified clinical research associates (CRA) has extensive effects. As clinical studies are becoming more expensive, and regulations being stringent, CROs are often forced to hire personnel that does not meet the qualification requirement to stay compliant with the budget. And this may somewhere lead to compromise in the quality of the service provided.
Competitive Landscape
The contract research organization (CRO) services market is marked by the presence of prominent players such as Syneos Health, Parexel International Corporation, IQVIA, Labcorp Drug Development, Charles River, ICON plc, PPD Inc., Novotech, WuXi AppTec, FIRMA CLINICAL. Other players operating in the market are AccuLab Life Sciences, Dove Quality Solutions, Pepgra, Azelix, Medpace, SGS SA, PSI, Bioagile, among others.
About Us
Clairvoyance Research is a leading market research and consulting firm, based out in Kolkata, India. Our research solutions are structured around the following verticals: Healthcare (Medical Devices, Biotechnology, Healthcare IT, Pharmaceuticals, and Others), Food & Beverage, Consumer Goods, Automotive & Transportation, Chemicals & Materials & Others.
Our main offerings are syndicate reports and consulting assignments – We track a number of verticals and strategically publish syndicated reports on topics that have traction in the market. Over the years, we have developed a forte in executing consulting assignments – Clairvoyance Research has been a trusted partner to over 300 global organizations including Fortune 500 companies. We partner with clients from across the globe to identify their highest-value opportunities, address their most critical challenges, and transform their enterprises. We have a rich pool of clientele spanning leading medical device/biotechnology/healthcare IT/pharmaceutical companies, IT/FMCG/automotive/food & beverage companies, consulting companies, private equity firms, venture capitalists, investment banks, government bodies, academic/research institutes, and universities.
We internally house one of the best talents in the industry – Industry Veterans [Subject Matter Experts (SMEs), Key Opinion Leaders (KOLs)] from different verticals with a profound experience of several decades are there on our panel. At each stage of the study, these experts add value to our reports and consulting assignments. We nurture crème de la crème resources; our analysts/consultants come from robust educational backgrounds. The rich pool of experts and analysts/consultants at Clairvoyance Research ensures that the final research study is accurate, universally accepted, and of the highest quality.
Contact Us
sales@clairvoyanceresearch.com
Website: www.clairvoyanceresearch.com
Contract Research, Development and Manufacturing (CRDMO) provides a fully integrated suite of end-to-end solutions for discovery, development, and manufacturing to meet all future market demands.
Cell and gene therapy (CGT) companies partner with CGT CDMOs to get support on discovery, preclinical, clinical stages, CGT product development, manufacturing, and commercial manufacturing.
A contract research organization (CRO) also known as a clinical research organization, is an organization that provides services to pharmaceutical, biotechnology, and medical device companies.
Wearable medical devices are electronic devices that are designed to collect the data of users' personal health and exercise. It offers a convenient means of monitoring many physiological features,...
A MedTech CDMO is a company that serves other companies in the medical device industry on contract basis and provides comprehensive services ranging from design & development, prototyping, tooling,...
Sleep apnea is a condition where breathing is interrupted during sleep. It is considered a serious sleep disorder in which breathing repeatedly stops and starts.
Telehealth is a broader array of digital healthcare activities & services and can be defined as distribution of health-related services & information including medical care, provider & patient educ...
Femtech is a term applied to a category of software, diagnostics, products and services that focus on women's health.
Remote patient monitoring (RPM) is a subset of telehealth. It is a technology that enables monitoring of patients outside of conventional clinical settings.
Micro-catheters are a broad term, often used to describe thin wall, small diameter catheters and delivery devices used in minimally invasive applications. Its small build makes it ideal for navigat...
3D printing also known as additive manufacturing is a process of making three dimensional solid objects from a CAD model or a digital 3D model. The term "3D printing" can refer to a variety of proc...
Hemophilia is a rare inherited bleeding disorder in which the blood does not clot properly which leads to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains prot...
The term halal is particularly associated with Islamic dietary laws and especially meat processed & prepared in accordance with those requirements. Halal is an Arabic word that means permissible. H...
Urinalysis is a test & analysis of urine to detect and manage a wide range of disorders, namely urinary tract infections, kidney disease and diabetes, among others. It includes a group of physical,...
Allergy is an exaggerated reaction by the immune system in response to exposure to certain foreign substances. These foreign substances are called as allergens and includes pollens, dust mites, mol...
Micro-catheters are a broad term, often used to describe thin wall, small diameter catheters and delivery devices used in minimally invasive applications. Its small build makes it ideal for navigat...
Remote patient monitoring (RPM) is a subset of telehealth. It is a technology that enables monitoring of patients outside of conventional clinical settings.
Femtech is a term applied to a category of software, diagnostics, products and services that focus on women's health.
Telehealth is a broader array of digital healthcare activities & services and can be defined as distribution of health-related services & information including medical care, provider & patient educ...
Sleep apnea is a condition where breathing is interrupted during sleep. It is considered a serious sleep disorder in which breathing repeatedly stops and starts.
A MedTech CDMO is a company that serves other companies in the medical device industry on contract basis and provides comprehensive services ranging from design & development, prototyping, tooling,...
Wearable medical devices are electronic devices that are designed to collect the data of users' personal health and exercise. It offers a convenient means of monitoring many physiological features,...
A contract research organization (CRO) also known as a clinical research organization, is an organization that provides services to pharmaceutical, biotechnology, and medical device companies.
Cell and gene therapy (CGT) companies partner with CGT CDMOs to get support on discovery, preclinical, clinical stages, CGT product development, manufacturing, and commercial manufacturing.
Contract Research, Development and Manufacturing (CRDMO) provides a fully integrated suite of end-to-end solutions for discovery, development, and manufacturing to meet all future market demands.